"Receptors, Urokinase Plasminogen Activator/metabolism"[MAJR] - Search Results

Year	Number of Results
2003	1
2006	2
2007	4
2008	27
2009	59
2010	46
2011	78
2012	82
2013	76
2014	113
2015	93
2016	66
2017	64
2018	53
2019	61
2020	53
2021	46
2022	17
2023	8
2024	2

1

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.

Rasmussen LJH, Petersen JEV, Eugen-Olsen J. Rasmussen LJH, et al. Front Immunol. 2021 Dec 2;12:780641. doi: 10.3389/fimmu.2021.780641. eCollection 2021. Front Immunol. 2021. PMID: 34925360 Free PMC article. Review.

2

Plasminogen receptors.

Miles LA, Plow EF, Waisman DM, Parmer RJ. Miles LA, et al. J Biomed Biotechnol. 2012;2012:130735. doi: 10.1155/2012/130735. Epub 2012 Nov 20. J Biomed Biotechnol. 2012. PMID: 23226936 Free PMC article. No abstract available.

3

Urokinase plasminogen activator surface receptor restricts HIV-1 replication by blocking virion release from the cell membrane.

Pang H, Ouyang J, Yang Z, Shang H, Liang G. Pang H, et al. Proc Natl Acad Sci U S A. 2023 Jan 17;120(3):e2212991120. doi: 10.1073/pnas.2212991120. Epub 2023 Jan 13. Proc Natl Acad Sci U S A. 2023. PMID: 36638209 Free PMC article.

4

Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.

Zhai BT, Tian H, Sun J, Zou JB, Zhang XF, Cheng JX, Shi YJ, Fan Y, Guo DY. Zhai BT, et al. J Transl Med. 2022 Mar 18;20(1):135. doi: 10.1186/s12967-022-03329-3. J Transl Med. 2022. PMID: 35303878 Free PMC article. Review.

5

The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review.

Tucker TA, Idell S. Tucker TA, et al. Int J Mol Sci. 2021 Feb 1;22(3):1437. doi: 10.3390/ijms22031437. Int J Mol Sci. 2021. PMID: 33535429 Free PMC article. Review.

6

Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review.

Manzo P, Giudice V, Napolitano F, De Novellis D, Serio B, Moscato P, Montuori N, Selleri C. Manzo P, et al. Int J Mol Sci. 2023 Jun 23;24(13):10519. doi: 10.3390/ijms241310519. Int J Mol Sci. 2023. PMID: 37445697 Free PMC article. Review.

7

Soluble urokinase plasminogen activator receptor--a valuable biomarker in systemic lupus erythematosus?

Enocsson H, Sjöwall C, Wetterö J. Enocsson H, et al. Clin Chim Acta. 2015 Apr 15;444:234-41. doi: 10.1016/j.cca.2015.02.031. Epub 2015 Feb 19. Clin Chim Acta. 2015. PMID: 25704300 Free article. Review.

8

Imaging of Prostate Cancer Using Urokinase-Type Plasminogen Activator Receptor PET.

Skovgaard D, Persson M, Kjaer A. Skovgaard D, et al. PET Clin. 2017 Apr;12(2):243-255. doi: 10.1016/j.cpet.2016.12.005. Epub 2017 Jan 31. PET Clin. 2017. PMID: 28267457 Review.

9

So many plasminogen receptors: why?

Plow EF, Doeuvre L, Das R. Plow EF, et al. J Biomed Biotechnol. 2012;2012:141806. doi: 10.1155/2012/141806. Epub 2012 Oct 14. J Biomed Biotechnol. 2012. PMID: 23118495 Free PMC article. Review.

10

The urokinase-type plasminogen activator and the generation of inhibitors of urokinase activity and signaling.

Carriero MV, Stoppelli MP. Carriero MV, et al. Curr Pharm Des. 2011;17(19):1944-61. doi: 10.2174/138161211796718143. Curr Pharm Des. 2011. PMID: 21711235 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

804 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

804 results

Results by year